U.S. Authorises Experimental Ebola Treatment Amid Kenya Quarantine Resistance
Author: kenyans.co.kePublished on: June 5, 2026Country: Kenya
HealthWorld / International

The United States has authorized the experimental use of the MBP-134 antibody treatment for Ebola for high-risk individuals amid the Central Africa outbreak. Meanwhile, a planned 50-bed quarantine facility in Laikipia, Kenya, has sparked local protests. US and Kenyan authorities insist the facility is safe and part of a health security partnership.
Stay informed with NewsBoulevard
Get the latest news summaries delivered to your inbox


